摘要
基因治疗作为治疗多种疾病的强有力的替代物。它已被定义为产品,通过转录的遗传物质和/或整合到宿主基因组中的核酸、病毒或基因工程微生物来调节它们的作用。该产品可用于修改细胞在体内或转移到细胞体外前给受体。第一个治疗性基因治疗的人体试验是由Michael R. Blaese在1990进行的,除了它的潜力,Jesse Gelsinger悲剧死亡后技术遭受重大缺点,他的免疫反应对用于他的治疗病毒载体引起的。迄今为止,基因治疗又流行起来,超过2000个临床试验正在进行中,其中大部分与治疗或预防各种类型的癌症有关.。尽管如此,某些类型的癌细胞中含有罕见的干细胞样细胞,能够分化为肿瘤细胞,促进肿瘤的再发生。这些细胞一般对化疗和放疗更有弹性,与肿瘤的发生、发展、复发和转移有关.。人类前列腺癌(PCA)是高度异质性和多因素的,甚至标记是不准确的,足以预测的临床结果。此外,虽然目前的治疗方法可以有效地去除肿瘤,但是再发病率高。基因治疗提供了一些治疗方法,可以阻止癌基因的激活,促进抑制基因或靶向癌细胞的表达,并诱导细胞凋亡。除了涉及的风险,基因治疗可以在癌症和其他疾病的治疗有很大的帮助。本文旨在探讨不同基因治疗策略在癌症治疗中的安全性和潜力.
关键词: 基因治疗,主成分分析,诊断,治疗,病毒载体,MiRNA。
Current Gene Therapy
Title:Different Gene Therapy Strategies: A Overview for Prostate Cancer
Volume: 16 Issue: 4
Author(s): Aline Gomes de Souza, Victor Alexandre Felix Bastos, Isaura Beatriz Borges Silva, Karina Marangoni, Vivian Alonso Goulart
Affiliation:
关键词: 基因治疗,主成分分析,诊断,治疗,病毒载体,MiRNA。
摘要: Gene therapy emerged as a mighty alternative for conventional treatment of multiple diseases. It has been defined as a product “that mediate their effects by transcription and/or translation of transferred genetic material and/or by integrating into the host genome and that are administered as nucleic acids, viruses, or genetically engineered microorganisms. The products may be used to modify cells in vivo or transferred to cells ex vivo prior to administration to the recipient”. The first therapeutic gene therapy human trial was conducted in 1990 by Michael R. Blaese, and besides its potential, the technique suffered a major drawback after the tragical death of Jesse Gelsinger, caused by his immune response against the viral vector used in his treatment. To date, gene therapy has regained some popularity and more than 2000 clinical trials are ongoing, most of them related to the treatment or prevention of various types of cancer. Nevertheless, some types of cancer contain a rare population of stem-like cells, capable of differentiation into tumor cells, promoting the re-incidence of tumors. Those cells are generally more resilient to chemotherapy and radiotherapy and are related to tumor initiation, progression, recurrence and metastasis. The human prostate cancer (PCa) is highly heterogeneous and multifactorial, and even the markers are not precise enough to predict the clinical outcome. Furthermore, even though currently therapies can efficiently remove the tumors, the re-incidence rates are high. Gene therapy offers a handful of treatments that can halt oncogenes activation, promote the expression of suppressor genes or target cancer cells directly and induce apoptosis. Besides the risks involved, gene therapy can be of great help in the treatment of cancers and other diseases. This review aims to address the safety and potential of different gene therapy strategies used in the treatment of cancers.
Export Options
About this article
Cite this article as:
Aline Gomes de Souza, Victor Alexandre Felix Bastos, Isaura Beatriz Borges Silva, Karina Marangoni, Vivian Alonso Goulart , Different Gene Therapy Strategies: A Overview for Prostate Cancer, Current Gene Therapy 2016; 16 (4) . https://dx.doi.org/10.2174/1566523216666161115163044
DOI https://dx.doi.org/10.2174/1566523216666161115163044 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Donepezil May Reduce Insulin-Like Growth Factor-1 (IGF-1) Levels in Alzheimer’s disease
CNS & Neurological Disorders - Drug Targets Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery Efficient Production of Gossypol from Hairy Root Cultures of Cotton (Gossypium hirsutum L.)
Current Pharmaceutical Biotechnology Cytotoxic Tumor-Targeting Peptides From In Vivo Phage Display
Combinatorial Chemistry & High Throughput Screening Targeting p53-MDM2 Interaction Using Small Molecule Inhibitors and the Challenges Needed to be Addressed
Current Drug Targets Applications of Protein Microarray Technology
Combinatorial Chemistry & High Throughput Screening Meet Our Editorial Board Member:
Recent Patents on Anti-Cancer Drug Discovery Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches
Current Pediatric Reviews Nanomedicine to Overcome Cancer Multidrug Resistance
Current Drug Metabolism Druggable Orthosteric and Allosteric Hot Spots to Target Protein-protein Interactions
Current Pharmaceutical Design Shear-Wave and Strain Elastography: A Comparative Review on Principles, Basic Techniques and Applications.
Current Medical Imaging Hypoxia Signaling and the Metastatic Phenotype
Current Molecular Medicine Optical and Multimodal Peptide-Based Probes for In Vivo Molecular Imaging
Anti-Cancer Agents in Medicinal Chemistry Cell Penetrating Peptides for In Vivo Molecular Imaging Applications
Current Pharmaceutical Design In Search of the Most Suitable Lentiviral shRNA System
Current Gene Therapy Cell Metabolism Under Microenvironmental Low Oxygen Tension Levels in Stemness, Proliferation and Pluripotency
Current Molecular Medicine ExomiRs: A Novel Strategy in Cancer Diagnosis and Therapy
Current Gene Therapy Recent Developments in Boron Neutron Capture Therapy (BNCT) Driven by Nanotechnology
Current Chemical Biology Nutraceutical: A Drug, Dietary Supplement and Food Ingredient
Current Pharmacogenomics and Personalized Medicine Addressing Unmet Medical Needs in Type 2 Diabetes: A Narrative Review of Drugs under Development
Current Diabetes Reviews